K Jin Kim

Summary

Publications

  1. ncbi A novel monoclonal antibody to fibroblast growth factor 2 effectively inhibits growth of hepatocellular carcinoma xenografts
    Lihong Wang
    Galaxy Biotech, LLC, Sunnyvale, California 94089, USA
    Mol Cancer Ther 11:864-72. 2012
  2. ncbi Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts
    Wei Meng Zhao
    Galaxy Biotech, LLC, Sunnyvale, California 94089, USA
    Clin Cancer Res 16:5750-8. 2010

Research Grants

  1. Novel Monoclonal Antibody Therapy for Cancer
    K Jin Kim; Fiscal Year: 2006

Collaborators

  • Masakazu Yashiro
  • Lihong Wang
  • Hangil Park
  • Sophea Chhim
  • Wei Meng Zhao
  • Yi Ding
  • Cary Queen
  • Wei Jiang
  • Melanie Tanphanich

Detail Information

Publications2

  1. ncbi A novel monoclonal antibody to fibroblast growth factor 2 effectively inhibits growth of hepatocellular carcinoma xenografts
    Lihong Wang
    Galaxy Biotech, LLC, Sunnyvale, California 94089, USA
    Mol Cancer Ther 11:864-72. 2012
    ..Our report supports clinical testing of a humanized form of the GAL-F2 mAb for treatment of HCC and potentially other cancers...
  2. ncbi Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts
    Wei Meng Zhao
    Galaxy Biotech, LLC, Sunnyvale, California 94089, USA
    Clin Cancer Res 16:5750-8. 2010
    ..We investigated whether monoclonal antibodies (mAbs) directed against FGFR2 can inhibit the growth of tumors in xenograft models...

Research Grants1

  1. Novel Monoclonal Antibody Therapy for Cancer
    K Jin Kim; Fiscal Year: 2006
    ..abstract_text> ..